BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wollina U. Pyoderma gangrenosum--a review. Orphanet J Rare Dis. 2007;2:19. [PMID: 17433111 DOI: 10.1186/1750-1172-2-19] [Cited by in Crossref: 153] [Cited by in F6Publishing: 92] [Article Influence: 10.9] [Reference Citation Analysis]
Number Citing Articles
1 Baline K, Khadir K, Chiheb S, Marnissi F, Benchikhi H. [Deep-seated granulomatous pyoderma gangrenosum: A novel variant?]. Ann Dermatol Venereol 2015;142:340-5. [PMID: 25637110 DOI: 10.1016/j.annder.2014.11.010] [Reference Citation Analysis]
2 Bingoel AS, Krezdorn N, Kaltenborn A, Dastagir K, Jokuszies A, Mett TR, Vogt PM. The surgical approach to Pyoderma gangrenosum: A retrospective monocenter study. Wound Repair Regen 2021;29:478-85. [PMID: 33835625 DOI: 10.1111/wrr.12918] [Reference Citation Analysis]
3 Wang JY, French LE, Shear NH, Amiri A, Alavi A. Drug-Induced Pyoderma Gangrenosum: A Review. Am J Clin Dermatol 2018;19:67-77. [PMID: 28624960 DOI: 10.1007/s40257-017-0308-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 8.7] [Reference Citation Analysis]
4 Karimi K, Odhav A, Kollipara R, Fike J, Stanford C, Hall JC. Acute Cutaneous Necrosis: A Guide to Early Diagnosis and Treatment. J Cutan Med Surg 2017;21:425-37. [DOI: 10.1177/1203475417708164] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wu XR, Shen B. Diagnosis and management of parastomal pyoderma gangrenosum. Gastroenterol Rep (Oxf) 2013;1:1-8. [PMID: 24759661 DOI: 10.1093/gastro/got013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
6 Yamamoto T. Pyoderma gangrenosum: An important dermatologic condition occasionally associated with rheumatic diseases. WJR 2015;5:101. [DOI: 10.5499/wjr.v5.i2.101] [Cited by in CrossRef: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lee HS, Choi YR, Ha SH, Jeong JJ. Pyoderma Gangrenosum Mimicking a Diabetic Foot Infection: A Case Report. The Journal of Foot and Ankle Surgery 2013;52:67-71. [DOI: 10.1053/j.jfas.2012.09.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Marinopoulos S, Theofanakis C, Zacharouli T, Sotiropoulou M, Dimitrakakis C. Pyoderma Gangrenosum of the breast: A case report study. Int J Surg Case Rep 2017;31:203-5. [PMID: 28187399 DOI: 10.1016/j.ijscr.2017.01.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Kechichian E, Haber R, Mourad N, El Khoury R, Jabbour S, Tomb R. Pediatric pyoderma gangrenosum: a systematic review and update. Int J Dermatol. 2017;56:486-495. [PMID: 28233293 DOI: 10.1111/ijd.13584] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
10 Cunha VS, Magno V, Wendt LRR, Furian TQ, Passos EP. Pyoderma Gangrenosum Postlaparoscopy: A Rare Complication. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2012;22:e45-7. [DOI: 10.1097/sle.0b013e318241c120] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Wollina U. Pyoderma gangrenosum—a systemic disease? Clinics in Dermatology 2015;33:527-30. [DOI: 10.1016/j.clindermatol.2015.05.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
12 Abraham T, Kim YM, Casselman J, Saad A, Wessell KR, Toller-Artis E, Tcheurekdjian H, Hostoffer R. Multiple necrotic deep wound infections associated with a subcutaneous immunoglobulin infusion. Ann Allergy Asthma Immunol 2015;115:80-2. [PMID: 25963449 DOI: 10.1016/j.anai.2015.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Jha PK, Rana A, Kapoor S, Kher V. Pyoderma gangrenosum in a renal transplant recipient: A case report and review of literature. Indian J Nephrol 2015;25:297-9. [PMID: 26628796 DOI: 10.4103/0971-4065.156900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Rout AN, Sahu K, Sirka CS. Pyoderma Gangrenosum Over Hypertrophic Scar: Report of a Rare Presentation. Indian Dermatol Online J 2020;11:222-5. [PMID: 32477984 DOI: 10.4103/idoj.IDOJ_153_19] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Pellegrino SA, Cham A, Pitcher M. Pyoderma gangrenosum of the breast 17 years after breast cancer treatment. BMJ Case Rep 2020;13:e232983. [PMID: 32193178 DOI: 10.1136/bcr-2019-232983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gordon RA, Mays R, Sambrano B, Mayo T, Lapolla W. Antibiotics used in nonbacterial dermatologic conditions. Dermatol Ther 2012;25:38-54. [PMID: 22591498 DOI: 10.1111/j.1529-8019.2012.01496.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
17 Abraham ZS, Thomas EP, Kahinga AA. Unilateral Pyoderma gangrenosum of the external ear in a resource-limited setting: Case report and literature review. Clin Case Rep 2021;9:2016-8. [PMID: 33936632 DOI: 10.1002/ccr3.3930] [Reference Citation Analysis]
18 Tomasini C, Michelerio A. Erosive pustular dermatosis of the scalp: A neutrophilic folliculitis within the spectrum of neutrophilic dermatoses: A clinicopathologic study of 30 cases. J Am Acad Dermatol 2019;81:527-33. [PMID: 30617027 DOI: 10.1016/j.jaad.2018.10.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 5.3] [Reference Citation Analysis]
19 Ogata K, Takamori H, Ikuta Y, Tanaka H, Ozaki N, Hayashi H, Ogawa K, Doi K. Pyoderma gangrenosum in an abdominal surgical site: a case report. Surg Case Rep 2015;1:122. [PMID: 26943446 DOI: 10.1186/s40792-015-0124-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Kolios A, Maul J, Meier B, Kerl K, Traidl‐hoffmann C, Hertl M, Zillikens D, Röcken M, Ring J, Facchiano A, Mondino C, Yawalkar N, Contassot E, Navarini A, French L. Canakinumab in adults with steroid‐refractory pyoderma gangrenosum. Br J Dermatol 2015;173:1216-23. [DOI: 10.1111/bjd.14037] [Cited by in Crossref: 54] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
21 Berbert ALCV, Mantese SADO, Rocha A, Rezende J, Cunha TFR. Pioderma granulomatoso superficial: relato de caso de variante rara do pioderma gangrenoso. An Bras Dermatol 2009;84:285-8. [DOI: 10.1590/s0365-05962009000300012] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
22 Mazokopakis EE, Kofteridis DP, Pateromihelaki AT, Vytiniotis SD, Karastergiou PG. Improvement of ulcerative pyoderma gangrenosum with hyperbaric oxygen therapy: Pyoderma gangrenosum and HBO therapy. Dermatologic Therapy 2011;24:134-6. [DOI: 10.1111/j.1529-8019.2010.01387.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Carmagnola D, Pispero A, Canciani E, Dellavia C, Barbieri C, Lodi G, Varoni EM. Dental treatment of a rare case of pyoderma gangrenosum with aggressive periodontal disease. J Am Dent Assoc 2018;149:794-800. [PMID: 29945713 DOI: 10.1016/j.adaj.2018.04.025] [Reference Citation Analysis]
24 Al Ghazal P, Herberger K, Schaller J, Strölin A, Hoff NP, Goerge T, Roth H, Rabe E, Karrer S, Renner R. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis. 2013;8:136. [PMID: 24010984 DOI: 10.1186/1750-1172-8-136] [Cited by in Crossref: 76] [Cited by in F6Publishing: 43] [Article Influence: 9.5] [Reference Citation Analysis]
25 Diotallevi F, Campanati A, Radi G, Brisigotti V, Molinelli E, Brancorsini D, Offidani A. Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature. Dermatol Ther 2019;32:e12928. [PMID: 30980454 DOI: 10.1111/dth.12928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Jockenhöfer F, Gollnick H, Herberger K, Isbary G, Renner R, Stücker M, Valesky E, Wollina U, Weichenthal M, Karrer S, Kuepper B, Roesch A, Dissemond J. Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany. Int Wound J 2016;13:821-8. [PMID: 25483380 DOI: 10.1111/iwj.12387] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 4.9] [Reference Citation Analysis]
27 Tolkachjov SN, Wetter DA, Fahy AS, Nagorney DM, Camilleri MJ. Necrotic ulcerations after splenectomy. Int J Dermatol 2015;54:251-4. [DOI: 10.1111/ijd.12697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
28 Berlinrut I, Bhatia N, Josse JM, de Vinck D, Kaul S. Untreatable surgical site infection: consider pyoderma gangrenosum. Plast Reconstr Surg Glob Open 2014;2:e166. [PMID: 25289359 DOI: 10.1097/GOX.0000000000000114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Ehrl DC, Heidekrueger PI, Broer PN. Pyoderma gangrenosum after breast surgery: A systematic review. J Plast Reconstr Aesthet Surg 2018;71:1023-32. [PMID: 29748073 DOI: 10.1016/j.bjps.2018.03.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 6.7] [Reference Citation Analysis]
30 Gassman A, Sinno S, Milner R, Gamelli R. Pyoderma gangrenosum: a new complication after groin exposure for attempted endovascular aortic stent-graft placement. Vascular 2012;20:170-3. [DOI: 10.1258/vasc.2011.cr0263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Partridge ACR, Bai JW, Rosen CF, Walsh SR, Gulliver WP, Fleming P. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials. Br J Dermatol 2018;179:290-5. [PMID: 29478243 DOI: 10.1111/bjd.16485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
32 Hemp L, Hall S. Pyoderma gangrenosum: from misdiagnosis to recognition, a personal perspective. Journal of Wound Care 2009;18:521-6. [DOI: 10.12968/jowc.2009.18.12.45610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
33 Andrade P, Brites MM, Figueiredo A. Synchronous pyoderma gangrenosum and inflammatory bowel disease, healing after total proctocolectomy. An Bras Dermatol 2012;87:637-9. [PMID: 22892784 DOI: 10.1590/s0365-05962012000400022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Chokoeva AA, Cardoso JC, Wollina U, Tchernev G. Pyoderma gangrenosum—a novel approach? Wien Med Wochenschr 2017;167:58-65. [DOI: 10.1007/s10354-016-0472-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
35 Paula Tinoco M, Tamler C, Maciel G, Soares D, Carlos Avelleira J, Azulay D. Pyoderma gangrenosum following isotretinoin therapy for acne nodulocystic. International Journal of Dermatology 2008;47:953-6. [DOI: 10.1111/j.1365-4632.2008.03662.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
36 Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. 2017;18:355-372. [PMID: 28224502 DOI: 10.1007/s40257-017-0251-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 52] [Article Influence: 32.7] [Reference Citation Analysis]
37 Mckenzie F, Arthur M, Ortega-loayza AG. Pyoderma Gangrenosum: What Do We Know Now? Curr Derm Rep 2018;7:147-57. [DOI: 10.1007/s13671-018-0224-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
38 Wick MR, Patterson JW. Cutaneous paraneoplastic syndromes. Semin Diagn Pathol. 2019;36:211-228. [PMID: 30736994 DOI: 10.1053/j.semdp.2019.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
39 Yamasaki K, Yamanaka K, Zhao Y, Iwano S, Takei K, Suzuki K, Yamamoto T. Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study. J Dermatol 2020;47:1383-90. [PMID: 32804433 DOI: 10.1111/1346-8138.15533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
40 Jockenhöfer F, Herberger K, Schaller J, Hohaus KC, Stoffels-Weindorf M, Ghazal PA, Augustin M, Dissemond J. Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum. J Dtsch Dermatol Ges 2016;14:1023-30. [PMID: 27767288 DOI: 10.1111/ddg.12791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Ndour MA, Sow D, Diedhiou D, Senghor F, Diembou M, Diouf M, Faye A, Diallo IM, Barrage AL, Kabou LM, Mbaye MN, Sarr A. [A no scarring persistent skin lesion for 3 years pyoderma gangrenosum]. Pan Afr Med J 2019;32:198. [PMID: 31312310 DOI: 10.11604/pamj.2019.32.198.18692] [Reference Citation Analysis]
42 Lamet S, Bracke A, Geluykens E, Vlieghe E, Seymons K, Gadisseur A, Vrelust I, Van Marck V, Somville J, Lambert J. MEDICAL AND SURGICAL MANAGEMENT OF PARANEOPLASTIC PYODERMA GANGRENOSUM - A CASE REPORT AND REVIEW OF THE LITERATURE. Acta Clinica Belgica 2014;65:37-40. [DOI: 10.1179/acb.2010.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
43 Mori T, Hiraiwa T, Ohtsuka M, Yamamoto T. Late-onset pyoderma gangrenosum following surgical operation in a patient with malignant melanoma. J Dermatol 2015;42:650-1. [PMID: 25858495 DOI: 10.1111/1346-8138.12850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Reid AB, Stanley P, Grinsell D, Daffy JR. Severe, Steroid-responsive, Myositis Mimicking Necrotizing Fasciitis following Orthopedic Surgery: A Pyoderma Variant with Myonecrosis. Plast Reconstr Surg Glob Open 2014;2:e175. [PMID: 25289368 DOI: 10.1097/GOX.0000000000000124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
45 Thornburg DA, Aime V, James S, Gupta N, Bernard R, Johnson ML. Pyoderma Gangrenosum: A Rare Disease With Dire Consequences in Facial Aesthetic Surgery Patients. Aesthet Surg J 2021;41:NP709-16. [PMID: 33471065 DOI: 10.1093/asj/sjab026] [Reference Citation Analysis]
46 Kamel RA, Ong JF, Eriksson E, Junker JP, Caterson EJ. Tissue engineering of skin. J Am Coll Surg 2013;217:533-55. [PMID: 23816384 DOI: 10.1016/j.jamcollsurg.2013.03.027] [Cited by in Crossref: 88] [Cited by in F6Publishing: 67] [Article Influence: 11.0] [Reference Citation Analysis]
47 Baliu-piqué C, Mascaró JM. Multifocal and refractory pyoderma gangrenosum: Possible role of cocaine abuse. Australas J Dermatol 2017;58:e83-6. [DOI: 10.1111/ajd.12498] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
48 Solovan C, Smiszek R, Wickenhauser C, Chiticariu E. Postoperative pyoderma gangrenosum in association with renal cell carcinoma and chronic lymphocytic leukemia. Infect Dis Ther 2013;2:75-80. [PMID: 25135825 DOI: 10.1007/s40121-013-0008-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Shahid S, Myszor M, De Silva A. Pyoderma gangrenosum as a first presentation of inflammatory bowel disease. BMJ Case Rep. 2014;2014. [PMID: 25385558 DOI: 10.1136/bcr-2014-204853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Fernandez Armenteros JM, Veà Jódar A, Matas Nadal C, Cortés Pinto CP, Soria Gili X, Martí Laborda RM, Vilardell Villellas F, Casanova Seuma JM. Severe and recurrent levamisole-induced cutaneous vasculopathy. J Cutan Pathol 2018;45:309-11. [PMID: 29344981 DOI: 10.1111/cup.13105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Shah M, Sachdeva M, Gefri A, Jfri A. Paraneoplastic pyoderma gangrenosum in solid organ malignancy: a literature review. Int J Dermatol 2019;59:154-8. [DOI: 10.1111/ijd.14637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Steele RB, Nugent WH, Braswell SF, Frisch S, Ferrell J, Ortega-Loayza AG. Pyoderma gangrenosum and pregnancy: an example of abnormal inflammation and challenging treatment. Br J Dermatol 2016;174:77-87. [PMID: 26474193 DOI: 10.1111/bjd.14230] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
53 Berk DR, Bayliss SJ. Neutrophilic dermatoses in children. Pediatr Dermatol 2008;25:509-19. [PMID: 18950391 DOI: 10.1111/j.1525-1470.2008.00765.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
54 Jockenhöfer F, Wollina U, Salva KA, Benson S, Dissemond J. The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum. Br J Dermatol 2019;180:615-20. [PMID: 29388188 DOI: 10.1111/bjd.16401] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
55 Ruffer N, Krusche M, Holzer MT, Hagel C, Kötter I. [Differential diagnosis of a vasculitic syndrome of the lower limb]. Z Rheumatol 2021. [PMID: 34241690 DOI: 10.1007/s00393-021-01044-w] [Reference Citation Analysis]
56 Wollina U. [Cutaneous calciphylaxis]. Hautarzt 2010;61:1063-71; quiz 1072. [PMID: 21103856 DOI: 10.1007/s00105-010-2026-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
57 Uchino M, Ikeuchi H, Matsuoka H, Bando T, Takahashi Y, Takesue Y, Matsumoto T, Tomita N. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease. Digestion. 2012;85:295-301. [PMID: 22584791 DOI: 10.1159/000336719] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
58 Lu JD, Milakovic M, Ortega-Loayza AG, Marzano AV, Alavi A. Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1. Expert Opin Investig Drugs 2020;29:1179-85. [PMID: 32880206 DOI: 10.1080/13543784.2020.1819981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
59 Wollina U, Tchernev G. Pyoderma gangrenosum: pathogenetic oriented treatment approaches. Wien Med Wochenschr 2014;164:263-73. [DOI: 10.1007/s10354-014-0285-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
60 Bhat RM. Pyoderma gangrenosum: An update. Indian Dermatol Online J 2012;3:7-13. [PMID: 23130252 DOI: 10.4103/2229-5178.93482] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
61 Vojvodic A, Tirant M, Nardo VD, Lotti T, Wollina U. Immunocompromised Districts of Skin: A Case Series and a Literature Review. Open Access Maced J Med Sci 2019;7:2969-75. [PMID: 31850101 DOI: 10.3889/oamjms.2019.680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Cañas CA, Durán CE, Bravo JC, Castaño DE, Tobón GJ. Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation. Rheumatol Int 2010;30:1253-7. [DOI: 10.1007/s00296-010-1418-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
63 Genovese G, Tavecchio S, Berti E, Rongioletti F, Marzano AV. Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review. Rheumatol Int 2018;38:1139-51. [PMID: 29721696 DOI: 10.1007/s00296-018-4035-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
64 Halac U, Dhaybi RA, Powell J, Soglio DB, Alvarez F. Unusual Association Between Autoimmune Hepatitis and Severe Pyoderma Gangrenosum. Journal of Pediatric Gastroenterology & Nutrition 2010;50:219-21. [DOI: 10.1097/mpg.0b013e31819a62f5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
65 Androutsakos T, Stamopoulos P, Aroni K, Hatzis G. A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature. BMC Gastroenterol 2015;15:149. [PMID: 26502871 DOI: 10.1186/s12876-015-0376-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
66 Miyata T, Yashiro M, Hayashi M, Kamata K, Katsuoka K. Bullous pyoderma gangrenosum of the bilateral dorsal hands. J Dermatol 2012;39:1006-9. [PMID: 23039059 DOI: 10.1111/j.1346-8138.2012.01672.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Swindell WR, Gau J. Pyoderma Gangrenosum–Like Lesion in an Older Adult. Journal of Osteopathic Medicine 2019;119:700-3. [DOI: 10.7556/jaoa.2019.117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Johnston SL. Clinical immunology review series: an approach to the patient with recurrent superficial abscesses. Clin Exp Immunol 2008;152:397-405. [PMID: 18422735 DOI: 10.1111/j.1365-2249.2008.03640.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
69 Bazaliński D, Karwiec A, Kucharzewski M, Więch P. Negative Pressure Wound Therapy in Pyoderma Gangrenosum Treatment. Am J Case Rep 2020;21:e922581. [PMID: 32520925 DOI: 10.12659/AJCR.922581] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Wollina U, Haroske G. Pyoderma gangraenosum. Current Opinion in Rheumatology 2011;23:50-6. [DOI: 10.1097/bor.0b013e328341152f] [Cited by in Crossref: 57] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
71 Campanati A, Brisigotti V, Ganzetti G, Molinelli E, Giuliodori K, Consales V, Racchini S, Bendia E, Offidani A. Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature. J Eur Acad Dermatol Venereol 2015;29:1245-7. [PMID: 25200926 DOI: 10.1111/jdv.12703] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
72 Gameiro A, Pereira N, Cardoso JC, Gonçalo M. Pyoderma gangrenosum: challenges and solutions. Clin Cosmet Investig Dermatol 2015;8:285-93. [PMID: 26060412 DOI: 10.2147/CCID.S61202] [Cited by in Crossref: 49] [Cited by in F6Publishing: 8] [Article Influence: 8.2] [Reference Citation Analysis]
73 Ebrad S, Severyns M, Benzakour A, Roze B, Derancourt C, Odri GA, Rouvillain JL. Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature. Int Orthop 2018;42:239-45. [PMID: 29119297 DOI: 10.1007/s00264-017-3672-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Parren LJMT, Nellen RGL, van Marion AMW, Henquet CJM, Frank J, Poblete-gutiérrez P. Penile pyoderma gangrenosum: successful treatment with colchicine. International Journal of Dermatology 2008;47:7-9. [DOI: 10.1111/j.1365-4632.2008.03949.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
75 Madkaikar M, Italia K, Gupta M, Desai M, Aggarwal A, Singh S, Suri D, Mishra A, Chavan S, Ghosh K, Sarangal R, Dogra S. Leukocyte Adhesion Deficiency-I with a Novel Intronic Mutation Presenting with Pyoderma Gangrenosum- Like Lesions. J Clin Immunol 2015;35:431-4. [DOI: 10.1007/s10875-015-0155-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
76 Ratnagobal S, Sinha S. Pyoderma gangrenosum: guideline for wound practitioners. Journal of Wound Care 2013;22:68-72. [DOI: 10.12968/jowc.2013.22.2.68] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
77 Briffa J, Wang YT, Murphy L, Bunker D, Kode G. Post-surgical pyoderma gangrenosum as a cause of unexplained wound breakdown. ANZ J Surg 2021. [PMID: 34365724 DOI: 10.1111/ans.17130] [Reference Citation Analysis]
78 Flanagan KE, Krueger S, Amano S, Auerbach A, St John J, Deng A. Sweet syndrome with perifollicular involvement because of koebnerization from facial hair plucking. J Cutan Pathol 2021;48:1189-92. [PMID: 33982315 DOI: 10.1111/cup.14061] [Reference Citation Analysis]
79 Bostan E, Günaydın SD, Karaduman A, Evans SE, Elçin G, Gülseren D, Okay M, Çöplü L. Excellent response to bortezomib in a patient with widespread ulcerative pyoderma gangrenosum accompanied by pulmonary involvement and IgA monoclonal gammopathy. Int Wound J 2019;16:1052-4. [PMID: 31044516 DOI: 10.1111/iwj.13135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Georgakopoulos JR, Rohekar G, Lovegrove FE. A case of rituximab-induced pyoderma gangrenosum. JAAD Case Rep 2018;4:979-81. [PMID: 30406172 DOI: 10.1016/j.jdcr.2018.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Jaimes-López N, Molina V, Arroyave JE, Vasquez LA, Ruiz AC, Castaño R, Ruiz MH. Development of pyoderma gangrenosum during therapy with infliximab. J Dermatol Case Rep 2009;3:20-3. [PMID: 21886723 DOI: 10.3315/jdcr.2009.1027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
82 Feldman SR, Lacy FA, Huang WW. The safety of treatments used in pyoderma gangrenosum. Expert Opinion on Drug Safety 2018;17:55-61. [DOI: 10.1080/14740338.2018.1396316] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
83 Kirsner RS. Biological agents for chronic wounds. Am J Clin Dermatol 2010;11 Suppl 1:23-5. [PMID: 20586502 DOI: 10.2165/1153417-S0-000000000-00000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Jockenhöfer F, Klode J, Kröger K, Roesch A, Al Ghazal P, Dissemond J. Patients with pyoderma gangrenosum - analyses of the German DRG data from 2012. Int Wound J 2016;13:951-6. [PMID: 26250591 DOI: 10.1111/iwj.12463] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
85 Bou-Dargham MJ, Khamis ZI, Cognetta AB, Sang QA. The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha. Med Res Rev 2017;37:180-216. [PMID: 27604144 DOI: 10.1002/med.21406] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
86 Barr KL, Chhatwal HK, Wesson SK, Bhattacharyya I, Vincek V. Pyoderma gangrenosum masquerading as necrotizing fasciitis. American Journal of Otolaryngology 2009;30:273-6. [DOI: 10.1016/j.amjoto.2008.05.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
87 Montagnon CM, Fracica EA, Patel AA, Camilleri MJ, Murad MH, Dingli D, Wetter DA, Tolkachjov SN. Pyoderma gangrenosum in hematologic malignancies: A systematic review. J Am Acad Dermatol 2020;82:1346-59. [PMID: 31560977 DOI: 10.1016/j.jaad.2019.09.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
88 Garcovich S, Gatto A, Ferrara P, Garcovich A. Vulvar Pyoderma Gangrenosum in a Child. Pediatric Dermatology 2009;26:629-31. [DOI: 10.1111/j.1525-1470.2009.01005.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
89 Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol. 2010;62:646-654. [PMID: 20227580 DOI: 10.1016/j.jaad.2009.05.030] [Cited by in Crossref: 134] [Cited by in F6Publishing: 78] [Article Influence: 12.2] [Reference Citation Analysis]
90 Na HD, Yan H, Park CH. Misdiagnosis of Pyoderma Gangrenosum Increases Medical Costs and Prolongs Hospital Stay: A Case Report. Int J Low Extrem Wounds 2021;:15347346211011870. [PMID: 33891524 DOI: 10.1177/15347346211011870] [Reference Citation Analysis]
91 Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 2009;10:301-12. [PMID: 19658442 DOI: 10.2165/11310730-000000000-00000] [Cited by in Crossref: 123] [Cited by in F6Publishing: 68] [Article Influence: 10.3] [Reference Citation Analysis]
92 Yuksel N, Ozdek S. Retinal vasculitis associated with pyoderma gangrenosum: a case report. J Ophthalmic Inflamm Infect 2012;2:239-41. [PMID: 22669709 DOI: 10.1007/s12348-012-0083-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]